药学与临床研究
藥學與臨床研究
약학여림상연구
PHARMACEUTICAL AND CLINICAL RESEARCH
2014年
6期
506-508
,共3页
利巴韦林%有关物质%氯化钠
利巴韋林%有關物質%氯化鈉
리파위림%유관물질%록화납
Ribavirion%Related substance%Sodium chloride
目的:对利巴韦林注射液有关物质检查方法进行探讨。方法:按照《中国药典》2010年版二部利巴韦林注射液有关物质检查的方法,对利巴韦林注射液进行破坏性试验,同时对利巴韦林的降解产物进行考察。结果:利巴韦林杂质峰与氯化钠峰难以分开。因此,利巴韦林注射液处方中如有氯化钠的存在,将干扰利巴韦林注射液有关物质的检查。结论:建议有关物质检测时扣除氯化钠峰的影响,或者企业在利巴韦林注射液的处方中标注氯化钠的量或不加氯化钠。
目的:對利巴韋林註射液有關物質檢查方法進行探討。方法:按照《中國藥典》2010年版二部利巴韋林註射液有關物質檢查的方法,對利巴韋林註射液進行破壞性試驗,同時對利巴韋林的降解產物進行攷察。結果:利巴韋林雜質峰與氯化鈉峰難以分開。因此,利巴韋林註射液處方中如有氯化鈉的存在,將榦擾利巴韋林註射液有關物質的檢查。結論:建議有關物質檢測時釦除氯化鈉峰的影響,或者企業在利巴韋林註射液的處方中標註氯化鈉的量或不加氯化鈉。
목적:대리파위림주사액유관물질검사방법진행탐토。방법:안조《중국약전》2010년판이부리파위림주사액유관물질검사적방법,대리파위림주사액진행파배성시험,동시대리파위림적강해산물진행고찰。결과:리파위림잡질봉여록화납봉난이분개。인차,리파위림주사액처방중여유록화납적존재,장간우리파위림주사액유관물질적검사。결론:건의유관물질검측시구제록화납봉적영향,혹자기업재리파위림주사액적처방중표주록화납적량혹불가록화납。
Objective: To discuss the related substance test method for ribavirin injections. Methods:The related substance test method for ribavirin injections in Chinese Pharmacopoeia Volume Ⅱ (2010 Edi_tion) was employed to determine the related substances in ribavirin injections of different manufacturers. Meanwhile, ribavirin injections were subjected to forced degradation studies under different conditions, and the degradation products of ribavirin were detected. Results: The HPLC of this related substance test method could not effectively separate the degradation product of ribavirin from sodium chloride. Conclu_sion: It is suggested that the peak area of sodium chloride should be deducted in the related substance test for ribavirin injections. In addition, the content of sodium chloride should be described in the pre_scriptions of ribavirin injections, or sodium chloride should not be included in ribavirin injections..